Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Watanabe

Showing results (341-350 of 510) with videos related to

Pageof 51
Sort By:
Inflammatory Bowel Diseases|May 5, 2018
Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative StudyMeng-Tzu Weng, Sang Hyoung Park, Katsuyoshi Matsuoka, et al.
Intestinal Research|May 9, 2024
Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studiesTaku Kobayashi, Katsuyoshi Matsuoka, Mamoru Watanabe, et al.
Journal of Gastroenterology|September 22, 2006
Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3Tsuyoshi Yamashiro, Naoya Sakamoto, Masayuki Kurosaki, et al.
Biochemical and Biophysical Research Communications|December 22, 2020
CEACAM1 specifically suppresses B cell receptor signaling-mediated activationNaoya Tsugawa, Daiki Yamada, Taro Watabe, et al.
Gastroenterology|February 28, 2004
Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel diseaseToshiro Sato, Takanori Kanai, Mamoru Watanabe, et al.
Surgery Today|February 1, 2018
Postoperative therapy with infliximab for Crohn's disease: a 2-year prospective randomized multicenter study in JapanKouhei Fukushima, Akira Sugita, Kitaro Futami, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 11, 2003
Teleconsultation practice guidelines: report from G8 Global Health Applications Subproject 4Michael Nerlich, E Andrew Balas, Thomas Schall, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replicationAkiko Kusano-Kitazume, Naoya Sakamoto, Yukiko Okuno, et al.
Biochemical and Biophysical Research Communications|May 17, 2021
Corrigendum to "CEACAM1 specifically suppresses B cell receptor signaling-mediated activation"Naoya Tsugawa, Daiki Yamada, Taro Watabe, et al.
Virology|October 24, 2007
Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacityYuko Sekine-Osajima, Naoya Sakamoto, Kako Mishima, et al.
Pageof 51

Showing results (341-350 of 510) with videos related to

Sort By:
Pageof 51
Inflammatory Bowel Diseases|May 5, 2018
Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative StudyMeng-Tzu Weng, Sang Hyoung Park, Katsuyoshi Matsuoka, et al.
Intestinal Research|May 9, 2024
Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studiesTaku Kobayashi, Katsuyoshi Matsuoka, Mamoru Watanabe, et al.
Journal of Gastroenterology|September 22, 2006
Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3Tsuyoshi Yamashiro, Naoya Sakamoto, Masayuki Kurosaki, et al.
Biochemical and Biophysical Research Communications|December 22, 2020
CEACAM1 specifically suppresses B cell receptor signaling-mediated activationNaoya Tsugawa, Daiki Yamada, Taro Watabe, et al.
Gastroenterology|February 28, 2004
Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel diseaseToshiro Sato, Takanori Kanai, Mamoru Watanabe, et al.
Surgery Today|February 1, 2018
Postoperative therapy with infliximab for Crohn's disease: a 2-year prospective randomized multicenter study in JapanKouhei Fukushima, Akira Sugita, Kitaro Futami, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 11, 2003
Teleconsultation practice guidelines: report from G8 Global Health Applications Subproject 4Michael Nerlich, E Andrew Balas, Thomas Schall, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replicationAkiko Kusano-Kitazume, Naoya Sakamoto, Yukiko Okuno, et al.
Biochemical and Biophysical Research Communications|May 17, 2021
Corrigendum to "CEACAM1 specifically suppresses B cell receptor signaling-mediated activation"Naoya Tsugawa, Daiki Yamada, Taro Watabe, et al.
Virology|October 24, 2007
Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacityYuko Sekine-Osajima, Naoya Sakamoto, Kako Mishima, et al.
Pageof 51